Saltar al contenido

Medpace Holdings, Inc. (MEDP) stock: revenue, earnings & dividend

Medpace Holdings, Inc. (MEDP, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener MEDP · Nasdaq Dienstleistungen US-OH

Key figures

Fiscal year
2025
Revenue
2.53 bn $
Revenue growth
20 %
Revenue growth 5y (p.a.)
22.3 %
Net income
451 m $
Net margin
17.8 %
Operating margin
21.1 %
Earnings per share (diluted)
15.28 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
1.98 bn $
Equity
459 m $
Equity ratio
23.2 %
Return on equity
98.3 %
Cash
497 m $
Operating cash flow
713 m $
Free cash flow
682 m $
Shares outstanding
27,971,686

History

Revenue by fiscal year

2016 422 m $
2017 436 m $
2018 705 m $
2019 861 m $
2020 926 m $
2021 1.14 bn $
2022 1.46 bn $
2023 1.89 bn $
2024 2.11 bn $
2025 2.53 bn $

Net income by fiscal year

2016 13.4 m $
2017 39.1 m $
2018 73.2 m $
2019 100 m $
2020 145 m $
2021 182 m $
2022 245 m $
2023 283 m $
2024 404 m $
2025 451 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20252.53 bn $451 m $15.28 $–713 m $
20242.11 bn $404 m $12.63 $–609 m $
20231.89 bn $283 m $8.88 $–433 m $
20221.46 bn $245 m $7.28 $–388 m $
20211.14 bn $182 m $4.81 $–263 m $
2020926 m $145 m $3.84 $–259 m $
2019861 m $100 m $2.67 $–202 m $
2018705 m $73.2 m $1.97 $–157 m $
2017436 m $39.1 m $0.98 $–97.4 m $
2016422 m $13.4 m $0.37 $–91.7 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)